White label ELPA - ClinicalTrials.eu

Study Comparing Short-Course Radiotherapy and Drug Combination for Older Patients with Locally Advanced Rectal Cancer

Recruiting

3 1 1 1
Investigated Drugs:
Study of Sacituzumab Govitecan for Patients with Advanced or Metastatic Bladder Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Transitional cell cancer of the renal pelvis and ureter
Investigated Drugs:
Study on MBK-01 and Drug Combination for Treating Patients with Recurrent Diverticulitis

Recruiting

2 1 1 1
Investigated Diseases:
- Diverticulitis
Investigated Drugs:
Study on Alpelisib for Treating Lymphatic Malformations in Patients with PIK3CA Mutation

Recruiting

4 1
Investigated Diseases:
- Lymphangioma
Investigated Drugs:
- Alpelisib
+1
Study Comparing Drug-Coated Balloon and Drug-Eluting Stents in Patients with Coronary Artery Disease at High Risk of Bleeding Using Acetylsalicylic Acid and Drug Combination

Recruiting

3 1 1 1
Investigated Diseases:
- Coronary artery disease
Investigated Drugs:
Study on Anti-T Lymphocyte Immunoglobulin for Children and Young Adults with Recent Type 1 Diabetes to Preserve Beta Cell Function

Recruiting

2 1 1 1
Investigated Diseases:
- Type 1 diabetes mellitus
Investigated Drugs:
- Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit
Study on Triamcinolone Acetonide Injections to Prevent Esophageal Strictures in Children with Esophageal Atresia

Recruiting

3 1 1 1
Investigated Diseases:
- Oesophageal atresia
Investigated Drugs:
- Triamcinolone Acetonide
Study on the Effect of Citalopram, Sertraline, and Lithium for Patients with Bipolar Depression After First-Line Treatment Failure

Recruiting

3 1 1 1
Investigated Drugs:
Study on Early Treatment Intensification for Acute Myeloid Leukemia with FLT3 Mutation Using Cytarabine, Midostaurin, and Daunorubicin Hydrochloride for Patients with Low Chemosensitivity

Recruiting

3 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
Study on the Use of [18F]PSMA-1007 PET/CT Imaging for Detecting Prostate Cancer in Patients with Newly Diagnosed High-Risk or Very-High-Risk Conditions

Recruiting

3 1 1 1
Investigated Diseases:
- Prostate cancer
Investigated Drugs:
- (2S)-2-[[(1S)-1-Carboxy-5-[[(2S)-2-[[4-[[[(2S)-4-Carboxy-2-[[(2S)-4-Carboxy-2-[(6-(18F)Fluoranylpyridine-3-Carbonyl)Amino]Butanoyl]Amino]Butanoyl]Amino]Methyl]Benzoyl]Amino]-3-Naphthalen-2-Ylpropanoyl]Amino]Pentyl]Carbamoylamino]Pentanedioic Acid

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies